ATE539349T1 - Verfahren zur diagnose einer pseudomonas aeruginosa infektion - Google Patents

Verfahren zur diagnose einer pseudomonas aeruginosa infektion

Info

Publication number
ATE539349T1
ATE539349T1 AT06000111T AT06000111T ATE539349T1 AT E539349 T1 ATE539349 T1 AT E539349T1 AT 06000111 T AT06000111 T AT 06000111T AT 06000111 T AT06000111 T AT 06000111T AT E539349 T1 ATE539349 T1 AT E539349T1
Authority
AT
Austria
Prior art keywords
pseudomonas aeruginosa
diagnosis
aeruginosa infection
infection
moderating
Prior art date
Application number
AT06000111T
Other languages
German (de)
English (en)
Inventor
Dara W Frank
Teiji Sawa
Timothy L Yahr
Jeanine Wiener-Kronish
Original Assignee
Mcw Res Found Inc
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcw Res Found Inc, Univ California filed Critical Mcw Res Found Inc
Application granted granted Critical
Publication of ATE539349T1 publication Critical patent/ATE539349T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/104Pseudomonadales, e.g. Pseudomonas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/21Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pseudomonadaceae (F)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/20Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
AT06000111T 1998-11-25 1999-11-23 Verfahren zur diagnose einer pseudomonas aeruginosa infektion ATE539349T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10995298P 1998-11-25 1998-11-25
US12679499P 1999-03-30 1999-03-30

Publications (1)

Publication Number Publication Date
ATE539349T1 true ATE539349T1 (de) 2012-01-15

Family

ID=26807543

Family Applications (2)

Application Number Title Priority Date Filing Date
AT06000111T ATE539349T1 (de) 1998-11-25 1999-11-23 Verfahren zur diagnose einer pseudomonas aeruginosa infektion
AT99971223T ATE318613T1 (de) 1998-11-25 1999-11-23 Verfahren und zusammensetzungen für impfung mit dem pseudomonas aeruginosa v-antigen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT99971223T ATE318613T1 (de) 1998-11-25 1999-11-23 Verfahren und zusammensetzungen für impfung mit dem pseudomonas aeruginosa v-antigen

Country Status (10)

Country Link
US (2) US6309651B1 (enExample)
EP (2) EP1666058B1 (enExample)
JP (2) JP4707234B2 (enExample)
AT (2) ATE539349T1 (enExample)
AU (1) AU3580800A (enExample)
CA (1) CA2318536C (enExample)
DE (1) DE69930166T2 (enExample)
DK (1) DK1049488T3 (enExample)
ES (2) ES2255329T3 (enExample)
WO (1) WO2000033872A2 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007231760B2 (en) * 2001-01-26 2009-10-29 Mcw Research Foundation, Inc. Method and compositions for immunization with the pseudomonas V antigen
WO2002064161A2 (en) * 2001-01-26 2002-08-22 Mcw Research Foundation, Inc. Method and compositions for immunization with the pseudomonas v antigen
DE10294091D2 (de) * 2001-09-13 2004-08-05 Hannover Med Hochschule Phänotyp bestimmende Virulenzgene von Pseudomonas aeruginosa zur Kolonisation und Persistenz in Mensch, Tier und Pflanze, Verwendungen der Gene und zugehörigen Proteine
WO2003058205A2 (en) * 2002-01-11 2003-07-17 Cornell Research Foundation, Inc. Methods of identifying putative effector proteins
CA2495725C (en) 2002-08-13 2013-06-25 Haptogen Ltd Methods for the treatment of an infectious bacterial disease with an anti-lactone or lactone derived signal molecules antibody
JP4782700B2 (ja) * 2004-01-20 2011-09-28 カロバイオス ファーマシューティカルズ インコーポレイティッド 最低限必須な結合決定基を用いた抗体特異性の移入
GB0407008D0 (en) 2004-03-27 2004-04-28 Haptogen Ltd Methods for inducing rapid cell death (autolysis) in infectious bacteria
GB0410958D0 (en) 2004-05-15 2004-06-16 Haptogen Ltd Methods for reducing biofilm formation in infectious bacteria
EP1946768A4 (en) 2005-10-28 2009-11-11 Meiji Seika Kaisha OUTER COAT PROTEIN PA5158 OF PSEUDOMONAS AERUGINOSA
AU2007232894B2 (en) 2006-03-30 2013-01-31 Meiji Seika Kaisha, Ltd. Pseudomonas aeruginosa outer membrane protein PA0427
CN101878302A (zh) * 2007-06-29 2010-11-03 明治制果株式会社 绿脓杆菌的外膜蛋白质pa4710
EA201000903A1 (ru) * 2007-11-30 2011-02-28 Калобиос Фармасьютикалс, Инк. Антитела к pcrv-антигену pseudomonas aeruginosa
CA2709500A1 (en) 2007-12-25 2009-07-02 Meiji Seika Kaisha, Ltd. Type iii secretion system component protein pa1698 of pseudomonas aeruginosa
BRPI0906810A2 (pt) * 2008-01-10 2019-10-01 Shionogi & Co anticorpo contra pcrv
EP2393515A1 (en) 2009-02-04 2011-12-14 Kalobios Pharmaceuticals, Inc. Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection
KR101686261B1 (ko) 2009-03-11 2016-12-14 시오노기세야쿠 가부시키가이샤 항녹농균 작용을 갖는 인간화 PcrV 항체
WO2011087799A1 (en) * 2009-12-22 2011-07-21 Kalobios Pharmaceuticals, Inc. A method of treating a staphylococcus infection in a patient having a low-level pathogenic pseudomonas aeruginosa infection
EP2726103B1 (en) * 2011-07-01 2018-09-05 The Trustees Of The University Of Pennsylvania Anti-properdin antibodies and uses thereof
BR112014011028B1 (pt) 2011-11-07 2021-03-02 Medimmune, Llc anticorpo biespecífico, composição, e, uso da composição
US9926366B2 (en) 2012-10-04 2018-03-27 Novelmed Therapeutics, Inc. Methods of treating a hemolytic disorder comprising administering anti-properdin antibodies
CN110028559B (zh) * 2019-04-15 2022-06-10 中国人民解放军陆军军医大学 一种铜绿假单胞菌疫苗重组蛋白及其编码基因和它们的应用
WO2021031270A1 (zh) * 2019-08-22 2021-02-25 四川大学 细菌膜囊泡及其分离制备系统和方法
WO2021113740A1 (en) * 2019-12-04 2021-06-10 The Research Foundation For The State University Of New York Compositions and methods for reducing off-target toxicity of antibody drug conjugates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3178014B2 (ja) * 1991-07-05 2001-06-18 東ソー株式会社 Rnaの測定方法
US5599665A (en) 1993-12-21 1997-02-04 Mcw Research Foundation Pseudomonas aeruginosa nucleic acids encoding exoenzyme S activity and use thereof in detecting pseudomonas aeruginosa infection

Also Published As

Publication number Publication date
CA2318536A1 (en) 2000-06-15
WO2000033872A2 (en) 2000-06-15
US20040208888A1 (en) 2004-10-21
DE69930166D1 (de) 2006-04-27
EP1666058B1 (en) 2011-12-28
JP2002531522A (ja) 2002-09-24
WO2000033872A3 (en) 2000-10-19
WO2000033872A9 (en) 2000-12-14
EP1666058A3 (en) 2008-03-12
ES2379801T3 (es) 2012-05-03
DE69930166T2 (de) 2006-12-14
AU3580800A (en) 2000-06-26
EP1049488B1 (en) 2006-03-01
JP4707234B2 (ja) 2011-06-22
ES2255329T3 (es) 2006-06-16
DK1049488T3 (da) 2006-06-26
EP1666058A2 (en) 2006-06-07
US6827935B2 (en) 2004-12-07
US6309651B1 (en) 2001-10-30
CA2318536C (en) 2009-11-17
ATE318613T1 (de) 2006-03-15
JP2011068672A (ja) 2011-04-07
EP1049488A1 (en) 2000-11-08

Similar Documents

Publication Publication Date Title
ATE539349T1 (de) Verfahren zur diagnose einer pseudomonas aeruginosa infektion
ATE347374T1 (de) Verfahren und zusammensetzungen für immunisierung mit dem pseudomonas antigen
DE3788787D1 (de) EINRICHTUNG ZUR EINSTELLUNG EINES HöRGERÄTES DURCH DEN PATIENTEN , VERFAHREN UND TESTEINRICHTUNG FÜR DIESES HöRGERÄT.
ATE338141T1 (de) Sonde zur diagnose einer ansteckenden krankheit verursacht durch pseudomonas aeruginosa
DE69627416D1 (de) Lichtsensor für Transmissionsmessungen an Gewebe
DE69629004D1 (de) Verfahren zur Herstellung einer elektronenemittierenden Vorrichtung.
DE60233485D1 (de) Verfahren zur diagnose, behandlung und prävention von knochenverlust
DE69606445D1 (de) Verfahren zur Herstellung einer Elektronen emittierenden Vorrichtung.
AU4694499A (en) Trace level detection of analytes using artificial olfactometry
SE8703694D0 (sv) Sett att lufta mellanorat medelst en insettbar ventilationstub, ventilationstub for utforande av settet jemte anvendning av en dylik ventilationstub
FR2733766B1 (fr) Methode de diagnostic de la schizophrenie
EP1269917A4 (en) INSTRUMENT AND METHOD FOR ANALYZING BIOLOGICAL INFORMATION
ATE374948T1 (de) Mittel und verfahren zur diagnose einer treponemainfektion
DK0946874T3 (da) Diagnose af Helicobacter Pylori
ATE275268T1 (de) Verfahren zur diagnose von sjögren-syndrom
DE68919674D1 (de) Verfahren und Gerät zur Diagnose von Netzwerken.
DE59610804D1 (de) Pyrogen-Untersuchungsverfahren
EP0671602A3 (en) Method and apparatus for transferring and adjusting a mechanically correct relationship for a transfer or adjusting instrument.
ATE211825T1 (de) Verfahren zur feststellung einer allergie
ATE256704T1 (de) Antikörper und diagnostizierverfahren zur pestivirusdiagnose
DE69527350D1 (de) Pyridinolin-quervernetzung als hinweis auf krankhafte vorgänge an periodontalen und peripheren implantaten
ATE377944T1 (de) Methode für die behandlung einer hepatitisvirusinfektion
DE69908688D1 (de) Verfahren zur Diagnose von HIV-Infektionen
ATE163229T1 (de) Verfahren zur immunologischen bestimmung eines oder mehrerer analyten
DE59707009D1 (de) Betätigungseinrichtung für eine Kupplung eines automatisierten Getriebes eines Fahrzeuges